Clinical Trial VICCBRE1277


Ultra-High Field (7 Tesla) MRI/MRS Evaluation of Breast Cancer

Principal Investigator(s)

Thomas Yankeelov


  • Protocol No. VICCBRE1277
  • Open Date: 01/01/2013
  • Staging: NA
  • Age Group: Adults
  • Scope: Local
  • Objective: The goal of this study is to implement quantitative DCE-MRI, DW-MRI, 31PMRS, MT-MRI, CEST-MRI, and high-resolution structural imaging at 7 Tesla in patients for diagnosing breast tumor status.
  • Disease Sites: Breast
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT01938651
  • Secondary Protocol No: Not Specified



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.